Sanofi-Aventis signs research deal with MIT
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has signed another research agreement with a US university. The new collaboration with the Massachusetts Institute of Technology Center for Biomedical Innovation will be called the Sanofi-Aventis Biomedical Innovation Program (SABIP), and the two parties hope that it will advance knowledge in human health through basic and applied research.